LipidDrive - Lipidomics cloud computing platform and app

Acronym

LipidDrive

Description of the granted funding

LipidDrive is a breakthrough cloud computing platform and mobile app that allows researchers in the growing field of lipidomics to process, store and share analytical data in a standardized format. Lipidomics is the study of lipid molecules in cells, tissues and biofluids. Due to its low cost, high accuracy and deep insights into cellular function, it has the potential to revolutionize medical science. However it is blocked by a lack of data standardization, processing capacity and collaboration. There are no common protocols for lipidomics data output. 70% of lipidomics data is incomparible, wasting €14 million in research costs annually. Tests require large computer processing power, which most researchers do not possess. There are few online resources for data collaboration. Addressing these challenges, LipidDrive is a cloud-based platform for high-quality lipidomics data analysis. Users upload mass spectrometry data sets, which are processed by algorithms to ensure quality control, and are output according to new data standards. LipidDrive’s cloud computing service processes high-throughput data in any format, replacing desktop-based software with limited capacity. It also provides an online resource of latest research, lipid and biomarker libraries, communication tools and APIs for third-party data utilization. LipidDrive is an unrivaled ICT service developed by Dr Kim Ekroos, a leading lipidomics expert. It will target researchers in universities, pharmaceutical and nutritional industries, and hospitals and clinics through direct sales and partnerships with hardware vendors. Demand and willingness to pay have been confirmed by interest from several large pharmaceutical companies. Lipidomics is expected to follow the growth path of proteomics, which is worth €20 billion annually. LipidDrive will become the most valuable online resource for this fast-emerging industry. The proposed feasibility study will test the technology and prepare for commercialization.
Show more

Starting year

2017

End year

2018

Granted funding

LIPIDOMICS CONSULTING OY AB - LIPIDOMICS CONSULTING LTD
Coordinator

Amount granted

50 000 €

Funder

European Union

Funding instrument

SME instrument phase 1

Framework programme

Horizon 2020 Framework Programme

Call

Programme part
INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) (5239)
Mainstreaming SME support, especially through a dedicated instrument (5284)
Health (5290)
Active ageing and self-management of health (5302)
Health care provision and integrated care (5309)
Topic
Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well (SMEInst-06-2016-2017)
Call ID
H2020-SMEINST-1-2016-2017

Other information

Funding decision number

781726

Identified topics

digitalisation, digital